Biopharmaceutical Science Symposium

University of Delaware Biopharmaceutical Symposium Logo

This symposium will explore the current landscape and emerging areas of biotherapeutics featuring thought-leaders from industry and academia. This day-long symposium will comprise of short talks, panel discussions and dialog to help inform the University of Delaware’s efforts in creating new programs that align and evolve with the needs of the broader biopharmaceutical/bioscience community.

Thusday, September 19, 2019 from 8:00 am – 5:00 pm
STAR Tower Audion, 100 Discovery Blvd., Newark, DE 19713

Keynote Speakers

Rombel Headshot

Irene Rombel
Sr. Director, Head of Strategic Analysis
Janssen Pharmaceuticals
“Innovation in the Biopharmaceutical Industry”

Wasserman Headshot

Gail Wasserman
Sr. Vice President
AstraZeneca
“Molecules to Medicines… technology continues to master the challenges”

Featured Speakers

Lenhoff Headshot

Abraham Lenhoff
Professor
University of Delaware
“The Science of Biopharmaceutical Manufacturing”

Nesta Headshot

Doug Nesta
Sr. Director
GlaxoSmithKline
“The Long & Winding Road- A Biopharm Development Journey”

Naso Headshot

Mike Naso
V.P. Cell Engineering
Century Therapeutics
“The Future of Engineered Cell Therapies”

Headshot

Jonathan Lai
Professor
Albert Einstein College of Medicine
“Structure-based design of flavivus immunogens”

Kossiakoff Headshot

Tony Kossiakoff
Professor
University of Chicago
“Recombinant Antibody Network: Model for Academic-Pharma Collaborations”

8:00 – 8:45am Arrival and Registration

8:45 – 9:00am Introduction

9:00 – 11:35am Speaker Session 1

  • Abraham Lenhoff, PhD, University of Delaware, “The Science of Biopharmaceutical Manufacturing”
  • Tony Kossiakoff, PhD, University of Chicago, “Recombinant Antibody Network: Model for Academic-Pharma Collaborations”
  • Doug Nesta, GSK, PhD, “The Long & Winding Road- A Biopharm Development Journey”

11:35 – 12:45pm Lunch

12:45 – 2:45pm Speaker Session 2

  • Jonathan Lai, PhD, Albert Einstein College of Medicine, “Structure-based design of flavivus immunogens”
  • Michael Naso, PhD, Century Therapeutics, “The Future of Engineered Cell Therapies”

2:45 – 5:00pm Keynote Session and Interview

  • Irene Rombel, PhD, Janssen Pharmaceuticals, “Preparing students for success and fulfillment in the life science industry”
  • Gail Wasserman, PhD, AstraZeneca, “Molecules to Medicines… technology continues to master the challenges”

Register Here